EPX
Eosinophil peroxidase
Also known as: EPO, EPP, EPX-PEN, PERE_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P11678
- Gene
- EPX
- Ensembl
- ENSG00000121053
- Chromosome
- 17
- Canonical length
- 715 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
OverviewNCBI Gene
This gene is a member of the peroxidase gene family and is expressed in eosinophils. The encoded preproprotein is proteolytically processed into covalently attached heavy and light chains to form the mature enzyme, which functions as an oxidant. The enzyme is released at sites of parasitic infection or allergen stimulation to mediate lysis of protozoa or parasitic worms. The gene is found in a gene cluster with other peroxidase genes on chromosome 17. Mutations in this gene result in eosinophil peroxidase deficiency. [provided by RefSeq, Feb 2016]
Canonical amino-acid sequenceUniProt
715 residues, UniProt reviewed canonical sequence.
>P11678|EPX
1 MHLLPALAGV LATLVLAQPC EGTDPASPGA VETSVLRDCI AEAKLLVDAA YNWTQKSIKQ
61 RLRSGSASPM DLLSYFKQPV AATRTVVRAA DYMHVALGLL EEKLQPQRSG PFNVTDVLTE
121 PQLRLLSQAS GCALRDQAER CSDKYRTITG RCNNKRRPLL GASNQALARW LPAEYEDGLS
181 LPFGWTPSRR RNGFLLPLVR AVSNQIVRFP NERLTSDRGR ALMFMQWGQF IDHDLDFSPE
241 SPARVAFTAG VDCERTCAQL PPCFPIKIPP NDPRIKNQRD CIPFFRSAPS CPQNKNRVRN
301 QINALTSFVD ASMVYGSEVS LSLRLRNRTN YLGLLAINQR FQDNGRALLP FDNLHDDPCL
361 LTNRSARIPC FLAGDTRSTE TPKLAAMHTL FMREHNRLAT ELRRLNPRWN GDKLYNEARK
421 IMGAMVQIIT YRDFLPLVLG KARARRTLGH YRGYCSNVDP RVANVFTLAF RFGHTMLQPF
481 MFRLDSQYRA SAPNSHVPLS SAFFASWRIV YEGGIDPILR GLMATPAKLN RQDAMLVDEL
541 RDRLFRQVRR IGLDLAALNM QRSRDHGLPG YNAWRRFCGL SQPRNLAQLS RVLKNQDLAR
601 KFLNLYGTPD NIDIWIGAIA EPLLPGARVG PLLACLFENQ FRRARDGDRF WWQKRGVFTK
661 RQRKALSRIS LSRIICDNTG ITTVSRDIFR ANIYPRGFVN CSRIPRLNLS AWRGTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EPX can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 32 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 32 nTPM
- thymus: 1.8 nTPM
- spleen: 1.2 nTPM
- cerebellum: 0.5 nTPM
- retina: 0.5 nTPM
- skin: 0.5 nTPM
Single-cell type
- retinal amacrine cells: 5.7 nCPM
- monocyte progenitors: 5 nCPM
- brain excitatory neurons: 4.2 nCPM
- sertoli cells: 3.9 nCPM
- fallopian tube ciliated cells: 3.5 nCPM
- brain inhibitory neurons: 3.3 nCPM
Immune cell
- eosinophil: 2.2 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 2.1 nTPM
- basal ganglia: 1.9 nTPM
- cerebral cortex: 1.8 nTPM
- hippocampal formation: 1.5 nTPM
- pons: 1.5 nTPM
- amygdala: 1.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about EPX.
Disease | AllUniProt
Conditions EPX is implicated in, by any mechanism.
- Eosinophil peroxidase deficiency (EPXD) MIM:261500
Disease | AutoantibodyPubMed
Conditions in which antibodies against EPX are reported. Each links to that disease's full target list.
Showing 0 of 1 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for EPX from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
9 publications
- Sputum autoantibodies in patients with severe eosinophilic asthma.
2018 · J Allergy Clin Immunol · RCR 4.2 · 104 citations - Presence of IgE Autoantibodies Against Eosinophil Peroxidase and Eosinophil Cationic Protein in Severe Chronic Spontaneous Urticaria and Atopic Dermatitis.
2021 · Allergy Asthma Immunol Res · RCR 4.1 · 50 citations - Impact of former smoking exposure on airway eosinophilic activation and autoimmunity in patients with severe asthma.
2022 · Eur Respir J · RCR 3.2 · 35 citations - Airway autoantibodies are determinants of asthma severity.
2022 · Eur Respir J · RCR 2.2 · 27 citations - Immunoglobulin E and G autoantibodies against eosinophil proteins in children and adults with asthma and healthy subjects.
2023 · World Allergy Organ J · RCR 1.9 · 14 citations
Show 4 more
- A novel specificity of anticytoplasmic autoantibodies directed against eosinophil peroxidase.
1993 · Clin Exp Immunol · RCR 0.4 · 11 citations - The Neutralization of the Eosinophil Peroxidase Antibody Accelerates Eosinophilic Mucin Decomposition.
2023 · Cells · RCR 0.3 · 2 citations - Anti-eosinophil peroxidase antibodies detected in patients with primary biliary cirrhosis.
2005 · Hepatol Res · RCR 0.2 · 8 citations - Identification of autoantigens and their potential post-translational modification in EGPA and severe eosinophilic asthma.
2023 · Front Immunol · RCR 0.1 · 1 citations
Reference: B cellIEDB
1 publication
- Epitope specificity of myeloperoxidase antibodies: identification of candidate human immunodominant epitopes.
2011 · Clin Exp Immunol · RCR 0.6 · 21 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.23
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.96
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- defense response to bacterium
- defense response to nematode
- hydrogen peroxide catabolic process
- negative regulation of interleukin-10 production
- negative regulation of interleukin-5 production
- negative regulation of macrophage cytokine production
- positive regulation of interleukin-4 production
- response to oxidative stress
- eosinophil migration
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EPX as an antibody target. Whether an autoantibody or antibody against EPX could matter depends on whether native EPX is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EPX is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EPX as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...